mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.002 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.003 |